印度对瑞士乙酰乙酸甲酯发起反倾销调查 智通财经7月9日电，印度商工部发布公告称，应印度企业提交的申请，对原产于或进口自瑞士的乙酰乙 酸甲酯发起反倾销调查。本案倾销调查期为2024年1月至2024年12月（12个月），损害调查期为2021年4 月至2022年3月、2022年4月至2023年3月、2023年4月至2024年3月及2024年1月至2024年12月。 ...

Core Viewpoint - The successful commissioning of the world's first 3000 tons/year ethane oxidative dehydrogenation (EDH) pilot plant at PetroChina Liaoyang Petrochemical Company marks a significant advancement in ethylene production technology, offering a more efficient and environmentally friendly alternative to traditional methods [1] Group 1: Technology and Innovation - The EDH technology, developed in collaboration with the Dalian Institute of Chemical Physics, eliminates the reliance on high-temperature steam cracking, using ethane and oxygen as primary raw materials [1] - The innovative process allows for the precise and efficient conversion of ethane into high-purity polymer-grade ethylene, while also co-producing high-value chemical products like acetic acid, significantly enhancing resource utilization and economic efficiency [1] - The high-performance catalyst developed by the company is crucial for achieving breakthroughs in activity, selectivity, and long-term stability, which are essential for low-temperature, efficient, and directional ethane conversion [1] Group 2: Environmental Impact - The EDH technology is viewed as a strong competitor for next-generation ethylene production due to its significantly lower energy consumption and production costs compared to traditional steam cracking processes [1] - The inherent characteristics of the oxidative dehydrogenation pathway and mild reaction conditions provide a substantial advantage in reducing carbon dioxide emissions, making it a viable option for the petrochemical industry to achieve carbon neutrality goals [1] Group 3: Future Plans - Liaoyang Petrochemical has established a comprehensive production plan that includes equipment debugging, operational procedure development, emergency response drills, and enhanced training for operators to ensure safe, stable, and efficient trial operations [2] - The company aims to lead with independent innovation by forming a cross-disciplinary team focused on optimizing operational parameters and verifying long-term operational stability, thereby addressing technical barriers for industrial-scale implementation [2]

据中国贸易救济信息网消息，2025年6月26日，印度商工部发布公告称，应印度生产商Laxmi Organics Industries Limited提交的申请，对原产于或进口自中国的乙酰乙酸甲酯（Methyl Acetoacetate）启动第二 次反倾销日落复审调查。本案倾销调查期为2024年1月～2024年12月（12个月），损害调查期为2021年4 月～2022年3月、2022年4月～2023年3月、2023年4月～2024年3月及倾销调查期。涉案产品的印度海关 编码为29183040、29146990、29153910、29153940、29153990、29183090、29331990、29410090和 29189900。 利益相关方应于立案之日起30天内以电子邮件（发送至：dd15-dgtr@gov.in、dir16-dgtr@gov.in、adv13- dgtr@gov.in）的方式向调查机关提交相关信息。 2015年1月7日，印度对原产于或进口自美国和中国的乙酰乙酸甲酯进行反倾销调查。2016年5月31日， 印度开始对中国和美国涉案产品征收反倾销税，其中，中国为0.277～0.404美元/千 ...

Core Viewpoint - Anhui Huaye Fragrance Co., Ltd. plans to issue shares through a simplified procedure to specific targets, which may dilute immediate returns, and has proposed measures to compensate for this dilution [2][6][14]. Financial Impact Analysis - The company estimates that the total amount raised from this issuance will be 113 million yuan, with a maximum of 22.4394 million shares to be issued [3][4]. - The financial impact of the issuance on key indicators has been analyzed under three scenarios regarding net profit for 2025 compared to 2024: a 10% increase, no change, and a 10% decrease [4][5]. - Before the issuance, the total share capital is 74.798 million shares, which will increase to 97.2374 million shares post-issuance [4]. Scenarios for Financial Indicators - **Scenario 1**: If the net profit increases by 10%, the basic earnings per share (EPS) will rise from 0.30 yuan to 0.32 yuan [4]. - **Scenario 2**: If the net profit remains unchanged, the EPS will stay at 0.30 yuan [4]. - **Scenario 3**: If the net profit decreases by 10%, the EPS will drop to 0.27 yuan [4]. Necessity and Reasonableness of the Issuance - The fundraising project is closely aligned with the company's main business and complies with national industrial policies, aiming to enhance market competitiveness and achieve sustainable development [6][7]. - The new production capacity will help maintain the company's leading position in the fragrance industry [6][10]. Measures to Mitigate Dilution Impact - The company will implement strict management and usage protocols for the raised funds to ensure effective and safe utilization [11][12]. - The company plans to accelerate the construction of the fundraising projects to achieve expected benefits as soon as possible [12]. - A profit distribution system will be established to enhance investor return mechanisms, ensuring continuous and stable profit distribution [12][13]. Commitments from Key Stakeholders - The company's board and senior management have committed to ensuring the effectiveness of the measures to compensate for the dilution of immediate returns [13][14]. - The controlling shareholder has also made commitments to uphold the measures aimed at protecting shareholder interests [14].

Core Viewpoint - Anhui Huaye Fragrance Co., Ltd. plans to raise up to RMB 113 million through a simplified procedure for a specific target stock issuance to enhance production capacity and competitiveness in the fragrance industry [1][6][8]. Group 1: Background and Purpose of the Issuance - The issuance aims to meet the funding needs for business development, expand operational scale, and enhance comprehensive competitiveness in line with national policies promoting high-quality development in the fragrance industry [2][4]. - The Ministry of Industry and Information Technology is promoting digitalization, greening, and upgrading of the fragrance industry, encouraging leading enterprises to accelerate technological upgrades and production line transformations [2][3]. Group 2: Market Potential and Growth - The global fragrance market was valued at approximately USD 30.6 billion in 2023, with a projected growth to USD 32.1 billion by 2025, reflecting a 2.3% annual growth rate [3][4]. - The domestic fragrance industry is expected to achieve a main business income of RMB 50 billion by 2025, with an average annual growth rate of over 2% [4][5]. Group 3: Use of Proceeds - The raised funds will be allocated to the first phase of a project aimed at producing 1,300 tons of fragrance annually, with a total investment of RMB 140.63 million [1][6]. - The company may initially use self-raised funds for the project and later replace them with the raised funds once available [1][6]. Group 4: Financial Structure and Risk Management - The issuance is expected to optimize the financial structure, reduce the debt-to-asset ratio, and enhance the company's financial strength and risk resistance [6][7]. - The company aims to avoid high financing costs associated with bank loans by opting for equity financing, which provides long-term stability [7][8]. Group 5: Issuance Process and Compliance - The issuance will target no more than 35 specific investors, including qualified institutional investors and individuals, ensuring compliance with relevant regulations [8][9]. - The pricing of the shares will be based on the average trading price over the 20 trading days prior to the pricing date, ensuring fairness in the issuance process [10][11]. Group 6: Project Viability and Strategic Fit - The fundraising project aligns with the company's core business and national industrial policies, enhancing market competitiveness and long-term sustainable development [21][27]. - The company has a well-established technical team and strong R&D capabilities, with numerous patents and industry recognition, supporting the project's success [22][25].

Core Viewpoint - Jiangsu Senxuan Pharmaceutical Co., Ltd. announced that its subsidiary, Ningxia Senxuan Pharmaceutical Co., Ltd., and its safety and environmental protection department head, Huang Xionghu, are being prosecuted for environmental pollution, with a recommended fine of 400,000 to 600,000 yuan [1][4]. Group 1: Legal Proceedings - Ningxia Senxuan is a subsidiary of Jiangsu Senxuan, primarily engaged in the production of pesticide intermediates [3][8]. - The prosecution stems from an incident on February 20, 2024, where due to a frozen wastewater discharge pipeline, Huang Xionghu arranged for untreated wastewater to be illegally disposed of, resulting in the dumping of approximately 150 tons of toxic waste [3][8]. - The public prosecutor claims that this act caused property damage amounting to 857,897.97 yuan [3][8]. Group 2: Company Background and Operations - Ningxia Senxuan was established in November 2018 with a registered capital of 70 million yuan and is a subsidiary of the state-owned enterprise Jinghua Pharmaceutical Group [4]. - The company focuses on the research, production, and sales of pharmaceuticals and intermediates, with Lin Guoping as the legal representative and Zhu Shizhang as the chairman [4]. Group 3: Impact on Company Operations - Following the incident, the company has taken corrective actions, including ceasing operations for rectification, which was later approved by the local environmental authority for resumption of production [11]. - The company emphasizes its commitment to compliance and environmental protection, stating it will manage the situation proactively and maintain transparency regarding the legal proceedings [11]. Group 4: Financial Implications - As of the announcement date, the case has not yet gone to trial, and the exact fine amount remains uncertain [12]. - The company plans to handle the financial implications according to accounting standards and will disclose relevant information as required [12].

Group 1 - The company, Jinghua Pharmaceutical Group Co., Ltd., is involved in a legal case where its subsidiary, Ningxia Senxuan Pharmaceutical Co., Ltd., is the defendant in a lawsuit initiated by Yinchuan Railway Transportation Procuratorate [1][2] - The lawsuit concerns the illegal disposal of approximately 150 tons of toxic waste, resulting in damages amounting to 857,897.97 yuan [2] - The company holds a 72.31% stake in Senxuan Pharmaceutical, which in turn owns 51% of Ningxia Senxuan, indicating a significant ownership structure that may influence the company's financials [3] Group 2 - As of the announcement date, there are no other significant lawsuits or arbitration matters involving the company or its subsidiaries that require disclosure [3] - The potential impact of the lawsuit on the company's current and future profits is considered minimal, as the lawsuit amount is small and is not expected to significantly affect the company's net profit for 2025 [3]

Group 1 - The core business of the company includes the manufacturing and sales of medical devices and pharmaceutical equipment, as well as providing medical services and trade [2] - The company is a leading entity in the Chinese medical device industry, holding several key positions in industry associations and has developed innovative products such as the world's first peracetic acid low-temperature sterilizer [2] - As of the first quarter of 2025, the company reported a revenue of 2.308 billion yuan, a year-on-year decrease of 8.74%, and a net profit of 160 million yuan, down 23.97% [3] Group 2 - The company's current rolling price-to-earnings (PE) ratio is 14.22, significantly lower than the industry average of 49.10 and the industry median of 36.43 [1][3] - The total market capitalization of the company is 9.118 billion yuan, ranking it 33rd in the medical device industry based on PE ratio [1] - As of the first quarter of 2025, 11 institutions hold shares in the company, with a total holding of 266.514 million shares valued at 4.283 billion yuan [1]

一、脱氢乙酸及其钠盐作为一种广谱食品防腐剂，对霉菌和酵母菌的抑制能力强，为苯甲酸钠的2~10倍，在高剂量使用时能抑制细菌。脱氢乙酸毒性较 低，按标准规定的范围和使用量使用是安全的。脱氢乙酸及其钠盐能被人体完全吸收，并能抑制人体内多种氧化酶，长期过量摄入脱氢乙酸及其钠盐会危害 健康。根据《食品安全国家标准 食品添加剂使用标准》（GB 2760-2014）的规定生湿面制品不得使用脱氢乙酸。脱氢乙酸超标的原因可能是个别生产经营 企业为防止食品腐败变质，超量使用了该添加剂，或者其使用的复配添加剂中该添加剂含量较高；也可能是在添加过程中未计量或计量不准。 福州经济技术开发区市场监督管理局关于2025年食品安全监督抽检信息的公告（第二期） 根据《中华人民共和国食品安全法》及其《实施条例》等规定，现将由福州经济技术开发区市场监督管理局开展的全区食品安全监督抽检信息公布如下，本 次公示88批次，其中合格86批次、不合格2批次。 二、防腐剂混合使用时各自用量占其最大使用量的比例之和，本要求最常见于防腐剂混合使用。在 GB 2760-2014《食品安全国家标准 食品添加剂使用标 准》表 A.1 中列出的具有同一功能的食品添加剂在 ...

"银行融资方面，公司与各大国有银行密切合作，发挥对华泰统一授信的优势，并与股份制银行结合， 实现了资金的低成本、高效运用。"李晓亮介绍，资金管控方面，公司充分利用旗下财务公司的优势， 发挥非银行金融机构功能，实现对集团资金的集中管控，通过资金集中管理、代理支付、人行再贴现融 资、财务公司海关保函以及上海票交所票据管理系统对票据集中管控等实现资金管理创新，同时，充分 发挥财务公司作为非银行金融机构的优势，积极参与公司项目银团贷款，保证公司资金需求和实现降本 增效。 近年来，造纸行业加快数智化转型升级，去年以来华泰股份智能化布局稳步推进，成为行业典型案例。 "公司加快布局智能工厂建设，投资建设的5G造纸工业云平台顺利启用，成为全省造纸行业首个省级工 业互联网平台。"李晓亮介绍，华泰股份积极探索大模型应用，加快建设山东省造纸"产业大脑"项目， 打造造纸数字化、智能化产业新生态，项目成功入选2024年度省级示范型"产业大脑"名单。 华泰股份总经理魏文光表示，华泰股份的数字化转型升级，聚焦研发、生产、供应链、营销、管理服务 一体化业务。"比如业务人员手机下单到信息化系统，从仓库发货到物流运输，货送达客户后的签收， 再到 ...